日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model

慢性粒细胞白血病 (CML) 急变模型中的嵌合抗原受体 (CAR) 工程化自然杀伤细胞

Jusuf Imeri, Paul Marcoux, Matthias Huyghe, Christophe Desterke, Daianne Maciely Carvalho Fantacini, Frank Griscelli, Dimas T Covas, Lucas Eduardo Botelho de Souza, Annelise Bennaceur Griscelli, Ali G Turhan

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)

使用诱变慢性粒细胞白血病衍生的诱导性多能干细胞 (iPSC) 模拟急变危机

Jusuf Imeri, Christophe Desterke, Paul Marcoux, Gladys Telliam, Safa Sanekli, Sylvain Barreau, Yucel Erbilgin, Theodoros Latsis, Patricia Hugues, Nathalie Sorel, Emilie Cayssials, Jean-Claude Chomel, Annelise Bennaceur-Griscelli, Ali G Turhan

Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)

RET 重排的非小细胞肺癌 (NSCLC) 建模:从患者来源的诱导性多能干细胞 (iPSC) 生成肺祖细胞 (LPC)

Paul Marcoux, Jin Wook Hwang, Christophe Desterke, Jusuf Imeri, Annelise Bennaceur-Griscelli, Ali G Turhan

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

奥拉帕尼与替莫唑胺联合治疗复发性小细胞肺癌

Anna F Farago, Beow Y Yeap, Marcello Stanzione, Yin P Hung, Rebecca S Heist, J Paul Marcoux, Jun Zhong, Deepa Rangachari, David A Barbie, Sarah Phat, David T Myers, Robert Morris, Marina Kem, Taronish D Dubash, Elizabeth A Kennedy, Subba R Digumarthy, Lecia V Sequist, Aaron N Hata, Shyamala Maheswar

A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors

新的 ALK 二次突变和 EGFR 信号导致对 ALK 激酶抑制剂产生耐药性

Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino, Masahiko Yanagita, Sarah Nikiforow, Wei Zheng, Christopher Lathan, J Paul Marcoux, Jinyan Du, Katsuhiro Okuda, Marzia Capelletti, Takeshi Shimamura, Dalia Ercan, Magda Stumpfova, Yun Xiao, Stanislawa Weremowicz, Mohit Butaney, Stephanie Heon, Keith Wilne

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

EML4-ALK 融合基因及 ALK 激酶抑制剂在肺癌中的疗效

Jussi P Koivunen, Craig Mermel, Kreshnik Zejnullahu, Carly Murphy, Eugene Lifshits, Alison J Holmes, Hwan Geun Choi, Jhingook Kim, Derek Chiang, Roman Thomas, Jinseon Lee, William G Richards, David J Sugarbaker, Christopher Ducko, Neal Lindeman, J Paul Marcoux, Jeffrey A Engelman, Nathanael S Gray,